We are live on
!
Find out more
TRCT
Tower Research Capital (TRC) Portfolio holdings
AUM
$3.85B
1-Year Est. Return
32.11%
This Fund
S&P 500
This Quarter
Est. Return
+2.09%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.48B
AUM Growth
-$164M
(-9.9%)
Cap. Flow
-$190M
Cap. Flow
% of AUM
-12.81%
Top 10 Holdings %
Top 10 Hldgs %
34.21%
Holding
4,786
New
885
Increased
1,268
Reduced
1,496
Closed
1,028
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$74.4M |
| 2 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$42.5M |
| 3 |
iShares Russell 2000 Growth ETF
IWO
|
+$24.2M |
| 4 |
VanEck Semiconductor ETF
SMH
|
+$17.4M |
| 5 |
iShares Russell 1000 Value ETF
IWD
|
+$12.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$105M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$29.3M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$12.8M |
| 4 |
Microsoft
MSFT
|
+$12.8M |
| 5 |
Apple
AAPL
|
+$11.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 5.52% |
| 2 | Technology | 4.3% |
| 3 | Healthcare | 3.85% |
| 4 | Consumer Discretionary | 3.73% |
| 5 | Financials | 3.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CMCM
1501
Cheetah Mobile
CMCM
$98.1M
| $58K | ﹤0.01% |
3,267
+1,610
| +97% | +$42.2K |
|
1502
Daily Journal
DJCO
$773M
| $58K | ﹤0.01% |
245
+134
| +121% | +$29.5K |
|
1503
GSK
GSK
$104B
| $58K | ﹤0.01% |
1,162
-7,192
| -86% | -$361K |
|
|
VNE
1504
DELISTED
Veoneer, Inc.
VNE
| $58K | ﹤0.01% |
3,342
-2,093
| -39% | -$43.9K |
|
|
TECD
1505
DELISTED
Tech Data Corp
TECD
| $58K | ﹤0.01% |
+558
| New | +$56.7K |
|
1506
Copa Holdings
CPA
$5.58B
| $57K | ﹤0.01% |
582
-1,063
| -65% | -$94.2K |
|
1507
Cisco
CSCO
$483B
| $57K | ﹤0.01% |
1,043
-63,982
| -98% | -$3.53M |
|
1508
iShares MSCI Philippines ETF
EPHE
$147M
| $57K | ﹤0.01% |
+1,589
| New | +$54.9K |
|
1509
FirstCash
FCFS
$9.05B
| $57K | ﹤0.01% |
572
-142
| -20% | -$13.5K |
|
1510
Jefferies Financial Group
JEF
$12.8B
| $57K | ﹤0.01% |
3,335
-21,524
| -87% | -$369K |
|
1511
Northern Trust
NTRS
$34.4B
| $57K | ﹤0.01% |
630
-3,888
| -86% | -$358K |
|
1512
Bank OZK
OZK
$5.63B
| $57K | ﹤0.01% |
1,884
-7,077
| -79% | -$219K |
|
1513
PBF Energy
PBF
$7.86B
| $57K | ﹤0.01% |
1,832
-5,781
| -76% | -$173K |
|
|
PPBI
1514
DELISTED
Pacific Premier Bancorp
PPBI
| $57K | ﹤0.01% |
+1,840
| New | +$54.2K |
|
1515
Surgery Partners
SGRY
$2.09B
| $57K | ﹤0.01% |
+7,095
| New | +$70.7K |
|
1516
Triumph Financial Inc
TFIN
$1.8B
| $57K | ﹤0.01% |
1,951
+1,820
| +1,389% | +$54.3K |
|
1517
Astrana Health
ASTH
$1.86B
| $57K | ﹤0.01% |
3,414
+3,203
| +1,518% | +$58.1K |
|
1518
Agnico Eagle Mines
AEM
$91.4B
| $56K | ﹤0.01% |
1,089
-7,441
| -87% | -$325K |
|
1519
Amneal Pharmaceuticals
AMRX
$5.71B
| $56K | ﹤0.01% |
7,766
+6,894
| +791% | +$70.5K |
|
1520
Independence Realty Trust
IRT
$3.94B
| $56K | ﹤0.01% |
+4,855
| New | +$53.3K |
|
1521
Oxford Industries
OXM
$556M
| $56K | ﹤0.01% |
+740
| New | +$56.6K |
|
1522
Qiagen
QGEN
$9.04B
| $56K | ﹤0.01% |
1,306
+1,209
| +1,246% | +$50.1K |
|
1523
T-Mobile US
TMUS
$191B
| $56K | ﹤0.01% |
749
+490
| +189% | +$36.4K |
|
1524
Tradeweb Markets
TW
$21.9B
| $56K | ﹤0.01% |
+1,288
| New | +$53.8K |
|
|
CALA
1525
DELISTED
Calithera Biosciences, Inc
CALA
| $56K | ﹤0.01% |
+724
| New | +$82.2K |
|
Similar funds
HFCIX
DWM
TFM
AC
IP
TCIM
FLSM
AFI
Tower Research Capital (TRC)'s Q2 2019 Portfolio in Review
As of Q2 2019, Tower Research Capital (TRC) held 4,786 positions worth $1.48B, down 9.9% from $1.65B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Tower Research Capital (TRC) withdrew a net $190M in Q2 2019, closing 1,028 positions and reducing 1,496 holdings. Its most notable exit was JPMorgan Chase, an estimated $7.56M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 5.5% of assets, up from 4.9% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard Morningstar Total Stock Market ETF worth $7.54M.
- Tower Research Capital (TRC)'s largest Q2 2019 buy was Vanguard Morningstar Total Stock Market ETF: 50,265 shares worth $7.54M.
- Tower Research Capital (TRC) added most to iShares Russell 1000 Growth ETF in Q2 2019, an estimated $74.4M increase.
- Tower Research Capital (TRC)'s biggest Q2 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $105M.
- Tower Research Capital (TRC) fully exited JPMorgan Chase in Q2 2019, selling an estimated $7.56M.
- Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $1.48B portfolio in Q2 2019.
- Tower Research Capital (TRC) opened 885 new positions and closed 1,028 in Q2 2019.
- Tower Research Capital (TRC)'s portfolio value fell 9.9% quarter-over-quarter to $1.48B.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2019, filed 13 Aug 2019.